Cannabis Law Report

AUGUST 2, 2021

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

NOVEMBER 24, 2021

Data collection. Only one article appeared in the MJA in 2000 and again in 2001. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. Drug Science. Matthew Johnson. Johns Hopkins University. in/ingmargorman/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51